UA-93693832-1skip to primary navigationskip to content

Repositive launch Autism Related Data Collection and celebrate 1000 users

The number of users of the Repositive platform has now reached over 1000 globally, which includes users from pharma, biotech and academia.

Repositive is a software company developing novel tools to improve discovery and access to human genomic data, offering a free-to-subscribe online platform for scientific researchers. The platform, a community-driven marketplace indexing worldwide genomic data sources through a single portal, allows its users to quickly identify the best data available for their research.

Repositive platform users not only benefit from the access to the largest portal for human genomic data, but also from the interactions with peer scientists with data interest and from the specialised collections of data. The latest collections include population genetics, epigenetics, microbiome and personal genomic data. The Repositive platform now boasts over 1,000,000 datasets including data from sources like ExAC, SRA, dbGaP, along with a number of data sources for personal and population genomes including Mike Lin’s genome, The Corpasome, The Genome of the Netherlands and The 1000 Genomes. For full press release click here 

Repositive has launched its latest Specialised Data Collection, this time focusing on Autism.

The Autism Data Collection contains over 6,500 datasets from 9 different data sources, and includes whole exome sequencing data from Autism patients, data sets describing the role of microRNA's in Autism, and data sets covering the role of gut microbiota in autism.

The largest proportion of the Autism data on Repositive is whole exome sequencing data found in the SRA (Sequencing Read Archive), a partnership between Baylor College of Medicine and the Broad Institute of MIT and Harvard. Alongside this, there are a number of miRNA-Seq datasets, which are thought to have a role in Autism pathophysiology through dysregulation. In addition, there over 150 datasets from gut microbiota samples from individuals involved in Autism studies. For full press release click here 





























        See Affiliated Companies